Researchers Debunk Classic Myths of Condition Often Seen in Critical Patients

Researchers have discovered that certain markers in a patient's blood do not necessarily mean they will develop RAI.
A study by researchers at the Paul L. Foster School of Medicine proves certain diagnostic markers do not predict relative adrenal insufficiency (RAI) in critically ill or injured patients.
RAI is a potentially life-threatening syndrome that results from inadequate basal or stress levels of plasma control, according to the U.S. National Library of Medicine. RAI is often under recognized and under diagnosed because current diagnostic tests are not sensitive enough to detect it.
Traditional teaching describes an association of hyponatremia (deficiency of sodium in body fluids), hyperkalemia (high levels of potassium in the blood), hypercalcemia (too much calcium in the blood), hypoglycemia (low blood sugar) and eosinophilia (high level of white blood cells) in patients with RAI.
“Relative Adrenal Insufficiency and the Critical Care Setting: Debunking the Classic Myth,” a research study conducted in the medical and surgical intensive care units of University Medical Center of El Paso, and led by Fatuma Kromah, M.D., contradicts the aforementioned theory. In fact, Kromah and his research team found that many patients with RAI who participated in the study had opposite results.
Kromah and his team also concluded that in the critical care setting, classic laboratory tests are of minimal value in predicting patients who may have RAI. Physicians treating patients with severe stress should instead obtain a random serum cortisol level to test for RAI.
“This study is a good example of opportunistic clinical research from colleagues making the extra effort while fully engaged in the setting of a very busy clinical environment,” said Richard McCallum, M.D., professor and chairman of the Department of Internal Medicine.
Researchers who assisted with the study include Alan Tyroch, M.D., and Susan McLean, M.D., in the Department of Surgery; Harold Hughes, M.D., and Nina Flavin, M.D., in the Department of Internal Medicine; and Soyoung Lee, MCIS, MCTS, an analyst in the Division of Biostatistics and Epidemiology.
Results of the study were recently published in the World Journal of Surgery.
Related Stories
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing
Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.
TTUHSC School of Nursing to Celebrate New YWCA Location
Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.
Recent Stories
Measles Outbreak: What to Know From The Future of Health
Kelissa Huse, an assistant professor and laboratory manager in the Molecular Pathology Program at TTUHSC, spoke about measles, the outbreak and what West Texans needs to know about the disease.
Santos Named Department of Surgery Chair for TTUHSC School of Medicine in Lubbock
As the new Department of Surgery chair for the School of Medicine in Lubbock, Ariel Santos, M.D., M.P.H., seeks to elevate TTUHSC’s role as the Hub of Surgery for West Texas.
Covenant Health Brings Kidney Transplant Surgery Back to West Texas
The Kidney Transplant Program at Covenant Medical Center will provide life-changing opportunities for patients suffering from end-stage renal disease (ESRD) and chronic kidney conditions.